In patients with relapsing MS, the transition to cladribine from natalizumab is a safe and effective option that provides sustained disease stability.
The Healthy on MSN2d
More Than 200,000 Containers of a Trusted Anxiety Medication Recalled Nationwide and in Puerto RicoThe recall reasoning is listed as “Failed impurities/degradation specifications and Sub-potent Drug,” which could signal the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback